Sign Up Today and Learn More About Accro Bioscience Stock
Invest in or calculate the value of your shares in Accro Bioscience or other pre-IPO companies through EquityZen's platform.
Accro Bioscience Stock
Accro Bioscience research centers on the molecular mechanism of regulated cell death such as necroptosis, pyroptosis, and ferroptosis.
About Accro Bioscience Stock
Founded
2016
Industries
Software, Artificial Intelligence, Data and Analytics
Accro Bioscience Press Mentions
Stay in the know about the latest news on Accro Bioscience
专注临床阶段的生物技术公司「爱科诺」完成5000万美元C轮融资
jixin • May 20, 2026
Accro Bioscience Raises $50M to Advance Ulcerative Colitis Drug Pipeline
ventureburn • May 20, 2026
Series C to fund Accro Bioscience’s mid-stage trial
thepharmaletter • May 20, 2026
Accro Bioscience: $50 Million Series C Raised To Advance Immune Mediated Disease Pipeline
pulse2 • May 20, 2026
Accro Bioscience Announces $50 Million Series C Financing Led by OrbiMed to Advance Clinical Pipeline for Immune Mediated Diseases
en • May 20, 2026
Join now and verify your accreditation status to gain access to:
- Accro Bioscience Current Valuation
- Accro Bioscience Stock Price
- Accro Bioscience Management
- Available deals in Accro Bioscience and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Accro Bioscience Cap Table and Funding History by Share Class and Liquidity Preferences
- Accro Bioscience Revenue and Financials
- Accro Bioscience Highlights
- Accro Bioscience Business Model
- Accro Bioscience Risk Factors
- Accro Bioscience Research Report from SACRA Research
Trading Accro Bioscience Stock
How to invest in Accro Bioscience stock?
Accredited investors can buy pre-IPO stock in companies like Accro Bioscience through EquityZen funds. These investments are made available by existing Accro Bioscience shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Accro Bioscience stock?
Shareholders can sell their Accro Bioscience stock through EquityZen's private company marketplace. EquityZen's network includes over 460K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 54K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."